Prevalence of anaemia in women screening for participation in a microbicide trial and the follow-up: a public health benefit.

Abstract

Anaemia is a common medical condition. Most anaemias go undetected until symptomatic. MDP 301 is a phase III microbicide trial. We conducted this study to determine prevalence of anaemia at screening and follow-up of enrolled HIV negative women in HPRU, Durban. METHODOLOGY: We conducted a retrospective CRF review of Hb level and HIV status of the first 1000 screening participants. Any Hb

Citation

Asmal, H. Prevalence of anaemia in women screening for participation in a microbicide trial and the follow-up: a public health benefit. Presented at Microbicides 2008, New Delhi, India, 24-27 February 2008. (2008)

Prevalence of anaemia in women screening for participation in a microbicide trial and the follow-up: a public health benefit.

Help us improve GOV.UK

Don’t include personal or financial information like your National Insurance number or credit card details.